Cell Therapies Pty Ltd Company Profile

21:22 EDT 22nd September 2018 | BioPortfolio

Cell Therapies Pty Ltd is in the business of planning and conducting clinical trials that involve the collection, manipulation and storage of blood cells and human tissue. The services range from laboratory rental through to fully-integrated planning and execution of clinical trials that involve cellular therapeutics manufactured in code of Good Manufacturing Practice (cGMP) and Therapeutic Goods Administration (TGA) licensed facilities.


105 Highgrove Drive
Chapel Hill
North Carolina
United States of America


Phone: (919) 969 1130

News Articles [1775 Associated News Articles listed on BioPortfolio]

FDA Sets Path for Stem Cell Therapies

(CNN) – Just months after the US Food and Drug Administration announced efforts to crack down on stem cell clinics touting unapproved therapies, the agency now plans to help expedite the develop...

In a bid to promote stem cell therapies, health officials open a new door for promising contenders

At a time when there’s significant hype around stem cell therapies, the FDA is moving to promote therapies that show the greatest potential.

BioLamina and Novo Nordisk Partner to Advance Stem Cell Based Therapies for Three Common ...

Novo Nordisk have announced today that they are increasing their commitment to cell therapies, including areas outside of diabetes. The three cell therapy projects they Read more...

What Lies Ahead for European Cell and Gene Therapies?

Cell and gene therapies have recently made big advances in providing effective treatments for a variety of conditions, from cancers to rare diseases. Nonetheless, there are still significant challenge...

Development of Next Generation CAR T cell therapies

Now that at two CAR T cell therapies have been approved by the FDA in two indications, what does the…

TCR² Raises $125M to Move Ahead with Its Cell Therapy, CAR-T’s Cousin

TCR² Therapeutics has raised a $125 million Series B round to push ahead with live, cancer-fighting T cells. T cell receptor (TCR) therapies, the firm’s area of focus, have not progressed as far as...

AbbVie and Calibr partner to develop T-cell therapies for cancer

AbbVie has formed an alliance with Scripps Research’s non-profit drug discovery unit Calibr to develop next-generation T-cell therapies that are...Read More... The post AbbVie and Calibr partner to ...

Orgenesis revenue nearly doubled in fiscal second quarter on CAR T-cell therapies

CEO Vered Caplan attributes his company's revenue growth to an expansion of services, particularly CAR T-cell therapies

Drugs and Medications [36 Associated Drugs and Medications listed on BioPortfolio]

Cladribine [Onco Therapies Limited ]

Cladribine Injection

Zolinza [Merck Sharp & Dohme Corp.]

These highlights do not include all the information needed to use ZOLINZA safely and effectively. See full prescribing information for ZOLINZA. ZOLINZA® (vorinostat) CapsulesInitial U.S. Approval: 20...

Humira [Abbott Laboratories]

These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescribing information for HUMIRA.HUMIRA (adalimumab) Injection, Solution for Subcutaneous us...

Sun care [Zenith Medicosm SL]

Drug Facts

Sun care [Zenith Medicosm SL]

Drug Facts

PubMed Articles [3625 Associated PubMed Articles listed on BioPortfolio]

Approved CAR T cell therapies: ice bucket challenges on glaring safety risks and long-term impacts.

Two autologous chimeric antigen receptor (CAR) T cell therapies (Kymriah™ and Yescarta™) were recently approved by the FDA. Kymriah™ for the treatment of pediatric patients and young adults with...

Advanced therapies in wound management: cell and tissue based therapies, physical and bio-physical therapies smart and IT based technologies.

Continuing Challenges in Advancing Preclinical Science in Skeletal Cell-Based Therapies and Tissue Regeneration.

Cell-based therapies hold much promise for musculoskeletal medicine; however, this rapidly growing field faces a number of challenges. Few of these therapies have proven clinical benefit, and an insuf...

With Probiotics, Resistance Is Not Always Futile.

Probiotics and other bacteriotherapies are actively being explored and applied as symptom- and disease-modifying agents. In a recent issue of Cell, two papers contribute to our understanding of how li...

Programming gene and engineered-cell therapies with synthetic biology.

Gene and engineered-cell therapies promise to treat diseases by genetically modifying cells to carry out therapeutic tasks. Although the field has had some success in treating monogenic disorders and ...

Clinical Trials [7832 Associated Clinical Trials listed on BioPortfolio]

Tracking Peripheral Blood Mononuclear Cells With Fluorine MRI

Cell-based therapies in the form of stem cell-based or immune cell-based therapies are becoming important treatment options that are either approved for clinical use or are showing promise...

Perceptions of Cell and Gene Therapies (CGT) for the Treatment of Cancer

Gene and cell therapies have a real value potential (example: potential long-term effect, curative potential, and single administration) but also drawbacks (example: treatment perceived as...

Phase Ib/II Trial of Interleukin-2 and PD-1 Checkpoint Inhibitor, Nivolumab In Metastatic Clear Cell Renal Cell Cancer

This will be a single arm, multi-site phase Ib/II clinical trial of standard doses of High Dose Interleukin-2 (HD IL2) (600,000 IU/kg/dose intravenously during two 5-day cycles 9 days apar...

Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma

The purpose of this study is to validate of a predictive nomogram of response or resistance to targeted therapies in metastatic clear cell renal cell carcinoma

Treatment of Chronic Lymphocytic Leukemia

CLL is a disease of the elderly, identifying effective therapies with better toxicity profiles is thus a high priority, and targeted therapies may allow attainment of this goal.

Companies [1742 Associated Companies listed on BioPortfolio]

Beike Biotechnology Company Limited

Beike Biotechnology ( is Asia's leading biotechnology company focusing on adult stem cell therapies. Beike's scientists have been focused on the development and commerc...

Beike Biotechnology Co. Ltd.

Beike Biotechnology ( ) is China's leading biotechnology company focusing on adult stem cell therapies. Beike's scientists have been focused on the development and comme...

Triumvira Immunologics, Inc.

Triumvira Immunologics, Inc. (“Triumvira”) is an immunotherapy company co-founded in 2015 by Dr. Jonathan Bramson at McMaster University and Bloom Burton & Co., with the...

Autolus Therapeutics Limited

Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and m...

Opexa Therapeutics

Opexa Therapeutics is a commercialization driven biotechnology cellular therapy company that develops autologous personalized cell therapies for the treatment of various diseases. The Company is focus...

More Information about "Cell Therapies Pty Ltd" on BioPortfolio

We have published hundreds of Cell Therapies Pty Ltd news stories on BioPortfolio along with dozens of Cell Therapies Pty Ltd Clinical Trials and PubMed Articles about Cell Therapies Pty Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cell Therapies Pty Ltd Companies in our database. You can also find out about relevant Cell Therapies Pty Ltd Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record